Stryker Net Income 2010-2025 | SYK

Stryker annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Stryker net income for the quarter ending March 31, 2025 was $654M, a 17.01% decline year-over-year.
  • Stryker net income for the twelve months ending March 31, 2025 was $2.859B, a 14.94% decline year-over-year.
  • Stryker annual net income for 2024 was $2.993B, a 5.43% decline from 2023.
  • Stryker annual net income for 2023 was $3.165B, a 34.22% increase from 2022.
  • Stryker annual net income for 2022 was $2.358B, a 18.25% increase from 2021.
Stryker Annual Net Income
(Millions of US $)
2024 $2,993
2023 $3,165
2022 $2,358
2021 $1,994
2020 $1,599
2019 $2,083
2018 $3,553
2017 $1,020
2016 $1,647
2015 $1,439
2014 $515
2013 $1,006
2012 $1,298
2011 $1,345
2010 $1,273
2009 $1,107
Stryker Quarterly Net Income
(Millions of US $)
2025-03-31 $654
2024-12-31 $546
2024-09-30 $834
2024-06-30 $825
2024-03-31 $788
2023-12-31 $1,143
2023-09-30 $692
2023-06-30 $738
2023-03-31 $592
2022-12-31 $563
2022-09-30 $816
2022-06-30 $656
2022-03-31 $323
2021-12-31 $662
2021-09-30 $438
2021-06-30 $592
2021-03-31 $302
2020-12-31 $568
2020-09-30 $621
2020-06-30 $-83
2020-03-31 $493
2019-12-31 $725
2019-09-30 $466
2019-06-30 $480
2019-03-31 $412
2018-12-31 $2,068
2018-09-30 $590
2018-06-30 $452
2018-03-31 $443
2017-12-31 $-249
2017-09-30 $434
2017-06-30 $391
2017-03-31 $444
2016-12-31 $510
2016-09-30 $355
2016-06-30 $380
2016-03-31 $402
2015-12-31 $522
2015-09-30 $301
2015-06-30 $392
2015-03-31 $224
2014-12-31 $260
2014-09-30 $57
2014-06-30 $128
2014-03-31 $70
2013-12-31 $386
2013-09-30 $103
2013-06-30 $213
2013-03-31 $304
2012-12-31 $270
2012-09-30 $353
2012-06-30 $325
2012-03-31 $350
2011-12-31 $401
2011-09-30 $327
2011-06-30 $310
2011-03-31 $307
2010-12-31 $295
2010-09-30 $337
2010-06-30 $319
2010-03-31 $322
2009-12-31 $306
2009-09-30 $229
2009-06-30 $291
2009-03-31 $281
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $152.939B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $219.828B 25.79
Boston Scientific (BSX) United States $156.585B 37.40
EssilorLuxottica (ESLOY) France $137.925B 0.00
Medtronic (MDT) Ireland $117.956B 16.72
Lonza Group Ag (LZAGY) Switzerland $49.343B 0.00
Haleon (HLN) United Kingdom $43.576B 24.87
ResMed (RMD) United States $40.103B 30.12
GE HealthCare Technologies (GEHC) United States $35.596B 16.90
Agilent Technologies (A) United States $33.957B 22.14
Terumo (TRUMY) Japan $25.643B 33.31
Koninklijke Philips (PHG) Netherlands $24.709B 17.34
Insulet (PODD) United States $20.568B 80.74
Zimmer Biomet Holdings (ZBH) United States $18.989B 12.20
Baxter (BAX) United States $14.636B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.656B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.891B 23.98
Lantheus Holdings (LNTH) United States $5.010B 12.64
Perrigo (PRGO) Ireland $3.867B 9.80
Prestige Consumer Healthcare (PBH) United States $3.770B 16.84
Haemonetics (HAE) United States $3.587B 16.34
Envista Holdings (NVST) United States $3.515B 29.21
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.138B 23.14
LeMaitre Vascular (LMAT) United States $1.863B 41.65
QuidelOrtho (QDEL) United States $1.764B 12.14
AtriCure (ATRC) United States $1.645B 0.00
Acuren (TIC) United States $1.367B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.96
AdaptHealth (AHCO) United States $1.294B 13.14
Neogen (NEOG) United States $1.176B 15.06
Phibro Animal Health (PAHC) United States $1.172B 14.98
BioLife Solutions (BLFS) United States $1.063B 0.00
Curaleaf Holdings (CURLF) Canada $0.987B 0.00
InMode (INMD) Israel $0.919B 9.26
Kestra Medical Technologies (KMTS) United States $0.847B 0.00
Tilray Brands (TLRY) Canada $0.704B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
Valneva SE (VALN) France $0.648B 0.00
Owens & Minor (OMI) United States $0.608B 5.04
Evolus (EOLS) United States $0.598B 0.00
CeriBell (CBLL) United States $0.541B 0.00
Surmodics (SRDX) United States $0.524B 0.00
ZimVie (ZIMV) United States $0.524B 23.82
SNDL (SNDL) Canada $0.394B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.358B 0.00
Cresco Labs (CRLBF) United States $0.329B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.97
Quanterix (QTRX) United States $0.324B 0.00
Capricor Therapeutics (CAPR) United States $0.310B 0.00
Sanuwave Health (SNWV) United States $0.306B 0.00
Aurora Cannabis (ACB) Canada $0.269B 79.67
Cerus (CERS) United States $0.260B 0.00
Omeros (OMER) United States $0.256B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.246B 20.77
Biote (BTMD) United States $0.239B 6.72
Verano Holdings (VRNOF) United States $0.238B 0.00
Brainsway (BWAY) Israel $0.227B 60.00
Canopy Growth (CGC) Canada $0.224B 0.00
Sanara MedTech (SMTI) United States $0.222B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.45
High Tide (HITI) Canada $0.184B 0.00
TriSalus Life Sciences (TLSI) United States $0.172B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.157B 0.00
TerrAscend (TSNDF) Canada $0.138B 0.00
FitLife Brands (FTLF) United States $0.120B 14.83
MacroGenics (MGNX) United States $0.105B 0.00
Jushi Holdings (JUSHF) United States $0.104B 0.00
Jin Medical (ZJYL) China $0.104B 0.00
Fonar (FONR) United States $0.099B 12.77
Quipt Home Medical (QIPT) United States $0.093B 0.00
Apyx Medical (APYX) United States $0.091B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Veru (VERU) United States $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Agape ATP (ATPC) $0.067B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
United-Guardian (UG) United States $0.039B 13.38
Nephros (NEPH) United States $0.038B 51.43
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00